New patents,
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
WO-2018033631
|
MARIZOMIB
|
CELGENE
|
CANCER
| |
2
|
WO-2018034901
|
ELAMIPRETIDE
|
STEALTH
|
Barth syndrome; Mitochondrial myopathy
| |
3
|
WO-2018033866
|
SACUBITRIL, VALSARTAN
|
NOVARTIS
|
CARDIAC FAILURE, HYPERTENSION
| |
4
|
WO-2018033149
|
OZANIMOD
|
CRYSTAL
|
Multiple sclerosis; Ulcerative colitis
| |
5
|
WO-2018033139
|
SOFOSBUVIR
|
CHIA
|
Hepatitis C virus infection
| |
6
|
WO-2018032521
|
LIRAGLUTIDE
|
SHENZEN
| Non-insulin dependent diabetes; Obesity | |
7
|
WO-2018032356
|
SOFOSBUVIR
|
PHARMARESOURCES
|
Hepatitis C virus infection
| |
8
|
WO-2018032796
|
SITAFLOXACIN
|
CHEN-STONE
|
Bacterial infection
| |
9
|
WO-2018033939
|
BUDESONIDE
|
ANANTCO
|
Allergic rhinitis; Inflammatory bowel disease; Irritable bowel syndrome
| |
new patents,
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
EP-03281941
|
LESINURAD
|
ZENTIVA
| Gout; Hyperuricemia | |
2
|
WO-2018029711
|
VENETOCLAX
|
MYLAN
|
Chronic lymphocytic leukemia
| |
3
|
WO-2018029699
|
BELINIOSTAT
|
MSN
|
Hematological neoplasm; Solid tumor
| |
4
|
WO-2018029264
|
DAPAGLIFLOZIN
|
AMNEAL
| Non-insulin dependent diabetes | |
5
|
WO-2018029223
|
GALETERONE
|
INDUSTRIALE
|
PROSTRATE TUMOR
| |
6
| WO-2018028508 |
PIRFENIDONE
|
IND
| Idiopathic pulmonary fibrosis | |
7
|
WO-2018028506
|
PIRFENIDONE
|
IND
| Idiopathic pulmonary fibrosis | |
8
|
WO-2018029611
|
DAPAGLIFLOZIN
|
LAURUS
| Non-insulin dependent diabetes | |
9
|
WO-2018028420
|
PLINABULIN
|
QUINGDAO
|
CANCER
| |
10
|
WO-2018028679
|
MIRABEGRON
|
ZHEJIANG
| Overactive bladder | |
